Back to RA CAPITAL MANAGEMENT, L.P.

TSHA
Showing 8 of 11 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in TAYSHA GENE THERAPIES INC

RA CAPITAL MANAGEMENT, L.P. holds 23.6M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $105.3M as of 2026-Q1. TSHA represents 1.1% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$105.3M

Current Shares

23.6M

Total Value Change

+$80.9M

Total Shares Change

+12.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
23.6M
0.0%
$105.3M1.1%$4.53
0
2025-Q4
Unchanged
23.6M
0.0%
$129.6M1.3%$5.66
0
2025-Q3
Unchanged
23.6M
0.0%
$77M0.9%$3.16
0
2025-Q2
Increased
23.6M
+116.7%
$54.4M0.9%$2.38
67
2025-Q1
Unchanged
10.9M
0.0%
$15.1M0.3%$1.93
0
2024-Q4
Unchanged
10.9M
0.0%
$18.8M0.3%$1.73
0
2024-Q3
Unchanged
10.9M
0.0%
$21.9M0.3%$2.07
0
2024-Q2
Unchanged
10.9M
0.0%
$24.4M0.3%$2.24
0

Other major holders of TSHA: Avoro Capital Advisors LLC, BlackRock, Inc., GOLDMAN SACHS GROUP INC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used